Search

Your search keyword '"Graham, Barney S."' showing total 1,719 results
Start Over Author "Graham, Barney S."
1,719 results on '"Graham, Barney S."'

201. Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans

Author

Burgomaster, Katherine E, primary, Foreman, Bryant M, additional, Aleshnick, Maya A, additional, Larman, Bridget C, additional, Gordon, David N, additional, Maciejewski, Sonia, additional, Morabito, Kaitlyn M, additional, Ledgerwood, Julie E, additional, Gaudinski, Martin R, additional, Chen, Grace L, additional, Mascola, John R, additional, Debbink, Kari, additional, Dowd, Kimberly A, additional, Graham, Barney S, additional, and Pierson, Theodore C, additional

Published
2021
Full Text
View/download PDF

202. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Author

Munoz, Flor M., primary, Cramer, Jakob P., additional, Dekker, Cornelia L., additional, Dudley, Matthew Z., additional, Graham, Barney S., additional, Gurwith, Marc, additional, Law, Barbara, additional, Perlman, Stanley, additional, Polack, Fernando P., additional, Spergel, Jonathan M., additional, Van Braeckel, Eva, additional, Ward, Brian J., additional, Didierlaurent, Arnaud M., additional, and Lambert, Paul Henri, additional

Published
2021
Full Text
View/download PDF

203. SARS-CoV-2 vaccines induce potent immune responses in infant rhesus macaques

Author

Curtis, Alan D, primary, Garrido, Carolina, additional, Dennis, Maria, additional, Gao, Hongmei, additional, Montefiori, David, additional, Van Rompay, Koen KA, additional, Tomai, Mark A, additional, Fox, Christopher, additional, Edwards, Darin, additional, Carfi, Andrea, additional, Corbett, Kizzmekia, additional, Graham, Barney S, additional, Permar, Sallie, additional, and De Paris, Kristina, additional

Published
2021
Full Text
View/download PDF

205. A single immunization with CAF08 provides newborns with Th1-mediated protection against Respiratory Syncytial Virus infection

Author

van Haren, Simon D., primary, Pedersen, Gabriel, additional, Kumar, Azad, additional, Ruckwardt, Tracy, additional, Moin, Syed, additional, Moore, Ian, additional, Minai, Mahnaz, additional, Liu, Mark, additional, Pak, Jensen, additional, Borriello, Francesco, additional, Ahmed, Saima, additional, Helmel, Michaela, additional, Andersen, Peter, additional, Graham, Barney S, additional, Steen, Hanno, additional, Christensen, Dennis, additional, and Levy, Ofer, additional

Published
2021
Full Text
View/download PDF

206. Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing $HIV-1_mn$ gpl20, $HIV-1_SF2$ Recombinant gp120, or Both Vaccines in Seronegative Adults

Author

NIAID AIDS Vaccine Evaluation Group, Clements-Mann, Mary Lou, Weinhold, Kent, Matthews, Thomas J., Graham, Barney S., Gorse, Geoffrey J., Keefer, Michael C., McElrath, M. Juliana, Hsieh, Ray-Hahn, Mestecky, Jiri, Zolla-Pazner, Susan, Mascola, John, Schwartz, David, Siliciano, Robert, Corey, Lawrence, Wright, Peter F., Belshe, Robert, Dolin, Raphael, Jackson, Susan, Xu, Serena, Fast, Patricia, Walker, Mary Clare, Stablein, Don, Excler, Jean-Louis, Tartaglia, James, Duliege, Anne-Marie, Sinangil, Faruk, and Paoletti, Enzo

Published
1998

207. Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines

Author

AIDS Vaccine Evaluation Group, Correlates of HIV Immune Protection Group, Graham, Barney S., McElrath, M. Juliana, Connor, Ruth I., Schwartz, David H., Gorse, Geoffrey J., Keefer, Michael C., Mulligan, Mark J., Matthews, Thomas J., Wolinsky, Steven M., Montefiori, David C., Vermund, Sten H., Lambert, John S., Corey, Lawrence, Belshe, Robert B., Dolin, Raphael, Wright, Peter F., Korber, Bette T., Wolff, Mark C., and Fast, Patricia E.

Published
1998

208. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

Author

Schäfer, Alexandra, Tilahun, Kedamawit, Seder, Robert, Li, Dapeng, Nagata, Bianca M., Feldman, Jared, Janowska, Katarzyna J., Baric, Ralph S., Manne, Kartik, Caradonna, Timothy M., Cronin, Kenneth, Denny, Thomas N., Moore, Ian N., Cain, Derek W., Zhou, Tongqing, Wang, Yunfei, Stover, Erica, Alam1, S. Munir, Minai, Mahnaz, Macintyre, Andrew N., Schmidt, Aaron G., Scobey, Trevor D., Bock, Kevin W., Tse, Longping V., Deyton, Margaret, Moody, M. Anthony, Barr, Maggie, Von Holle, Tarra, Perez, Lautaro G., Lee, Esther, Sutherland, Laura L., Montefiori, David C., Edwards, Robert J., Saunders, Kevin O., McDanal, Charlene, Hernandez, Giovanna E., Mansouri, Katayoun, Parks, Robert, Lu, Xiaozhi, Hauser, Blake M., DeMarco, C. Todd, Cai, Fangping, Graham, Barney S., Wiehe, Kevin, Mascola, John R., Sempowski, Gregory D., Andersen, Hanne, Petzold, Elizabeth W., Martinez, David R., Kwong, Peter D., Gee-Lai, Victoria, Kopp, Megan, Gobeil, Sophie M. C., Stalls, Victoria, Sanzone, Aja, Rountree, Wes, Haynes, Barton F., Lewis, Mark G., Acharya1, Priyamvada, Oguin III, Thomas H., Jiang, Chuancang, Teng, I-Ting, Foulger, Andrew, and Woods, Christopher W.

Subjects
viruses, fungi, respiratory system, skin and connective tissue diseases, respiratory tract diseases
Abstract

SARS-CoV-2 neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated NAbs against the receptor-binding domain (RBD) and the N-terminal domain (NTD) of SARS-CoV-2 spike from individuals with acute or convalescent SARS-CoV-2 or a history of SARS-CoV infection. Cryo-electron microscopy of RBD and NTD antibodies demonstrated function-specific modes of binding. Select RBD NAbs also demonstrated Fc receptor-g (FcgR)-mediated enhancement of virus infection in vitro, while five non-neutralizing NTD antibodies mediated FcgR-independent in vitro infection enhancement. However, both types of infection-enhancing antibodies protected from SARS-CoV-2 replication in monkeys and mice. Three of 46 monkeys infused with enhancing antibodies had higher lung inflammation scores compared to controls. One monkey had alveolar edema and elevated bronchoalveolar lavage inflammatory cytokines. Thus, while in vitro antibody-enhanced infection does not necessarily herald enhanced infection in vivo, increased lung inflammation can rarely occur in SARS-CoV-2 antibody-infused macaques.

Published
2021
Full Text
View/download PDF

209. Fc Glycan-Mediated Regulation of Placental Antibody Transfer

Author

Massachusetts Institute of Technology. Department of Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology. Center for Gynepathology Research, Jennewein, Madeleine F, Goldfarb, Ilona, Dolatshahi, Sepideh, Cosgrove, Cormac, Noelette, Francesca J, Krykbaeva, Marina, Das, Jishnu, Sarkar, Aniruddh, Gorman, Matthew J, Fischinger, Stephanie, Boudreau, Carolyn M, Brown, Joelle, Cooperrider, Jennifer H, Aneja, Jasneet, Suscovich, Todd J, Graham, Barney S, Lauer, Georg M, Goetghebuer, Tessa, Marchant, Arnaud, Lauffenburger, Douglas, Kim, Arthur Y, Riley, Laura E, Alter, Galit, Massachusetts Institute of Technology. Department of Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology. Center for Gynepathology Research, Jennewein, Madeleine F, Goldfarb, Ilona, Dolatshahi, Sepideh, Cosgrove, Cormac, Noelette, Francesca J, Krykbaeva, Marina, Das, Jishnu, Sarkar, Aniruddh, Gorman, Matthew J, Fischinger, Stephanie, Boudreau, Carolyn M, Brown, Joelle, Cooperrider, Jennifer H, Aneja, Jasneet, Suscovich, Todd J, Graham, Barney S, Lauer, Georg M, Goetghebuer, Tessa, Marchant, Arnaud, Lauffenburger, Douglas, Kim, Arthur Y, Riley, Laura E, and Alter, Galit

Abstract

© 2019 Elsevier Inc. Despite the worldwide success of vaccination, newborns remain vulnerable to infections. While neonatal vaccination has been hampered by maternal antibody-mediated dampening of immune responses, enhanced regulatory and tolerogenic mechanisms, and immune system immaturity, maternal pre-natal immunization aims to boost neonatal immunity via antibody transfer to the fetus. However, emerging data suggest that antibodies are not transferred equally across the placenta. To understand this, we used systems serology to define Fc features associated with antibody transfer. The Fc-profile of neonatal and maternal antibodies differed, skewed toward natural killer (NK) cell-activating antibodies. This selective transfer was linked to digalactosylated Fc-glycans that selectively bind FcRn and FCGR3A, resulting in transfer of antibodies able to efficiently leverage innate immune cells present at birth. Given emerging data that vaccination may direct antibody glycosylation, our study provides insights for the development of next-generation maternal vaccines designed to elicit antibodies that will most effectively aid neonates. Antibodies with a specific glycan modification and with the ability to activate NK cells are selectively transferred across the placenta to the neonate.

Published
2021

210. Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

Author

CTI Bont, Infectieziekten onderzoek1 (Bont), Child Health, Infection & Immunity, Salimi, Vahid, Viegas, Mariana, Trento, Alfonsina, Agoti, Charles N, Anderson, Larry J, Avadhanula, Vasanthi, Bahl, Justin, Bont, Louis, Brister, J Rodney, Cane, Patricia A, Galiano, Mónica, Graham, Barney S, Hatcher, Eneida L, Hellferscee, Orienka, Henke, David M, Hirve, Siddhivinayak, Jackson, Sandra, Keyaerts, Els, Kragten-Tabatabaie, Leyla, Lindstrom, Stephen, Nauwelaers, Inne, Nokes, D James, Openshaw, Peter J, Peret, Teresa C, Piedra, Pedro A, Ramaekers, Kaat, Rector, Annabel, Trovão, Nídia Sequeira, von Gottberg, Anne, Zambon, Maria, Zhang, Wenqing, Williams, Thomas C, Barr, Ian G, Buchholz, Ursula J, CTI Bont, Infectieziekten onderzoek1 (Bont), Child Health, Infection & Immunity, Salimi, Vahid, Viegas, Mariana, Trento, Alfonsina, Agoti, Charles N, Anderson, Larry J, Avadhanula, Vasanthi, Bahl, Justin, Bont, Louis, Brister, J Rodney, Cane, Patricia A, Galiano, Mónica, Graham, Barney S, Hatcher, Eneida L, Hellferscee, Orienka, Henke, David M, Hirve, Siddhivinayak, Jackson, Sandra, Keyaerts, Els, Kragten-Tabatabaie, Leyla, Lindstrom, Stephen, Nauwelaers, Inne, Nokes, D James, Openshaw, Peter J, Peret, Teresa C, Piedra, Pedro A, Ramaekers, Kaat, Rector, Annabel, Trovão, Nídia Sequeira, von Gottberg, Anne, Zambon, Maria, Zhang, Wenqing, Williams, Thomas C, Barr, Ian G, and Buchholz, Ursula J

Published
2021

213. Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

Author

Mascola, John R., Snyder, Stuart W., Weislow, Owen S., Belay, Seifu M., Belshe, Robert B., Schwartz, David H., Clements, Mary Lou, Dolin, Raphael, Graham, Barney S., Gorse, Geoffrey J., Keefer, Michael C., McElrath, M. Juliana, Walker, Mary Clare, Wagner, Kenneth F., McNeil, John G., McCutchan, Francine E., and Burke, Donald S.

Published
1996

214. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Author

Westendorf, Kathryn, primary, Žentelis, Stefanie, additional, Wang, Lingshu, additional, Foster, Denisa, additional, Vaillancourt, Peter, additional, Wiggin, Matthew, additional, Lovett, Erica, additional, van der Lee, Robin, additional, Hendle, Jörg, additional, Pustilnik, Anna, additional, Sauder, J. Michael, additional, Kraft, Lucas, additional, Hwang, Yuri, additional, Siegel, Robert W., additional, Chen, Jinbiao, additional, Heinz, Beverly A., additional, Higgs, Richard E., additional, Kallewaard, Nicole L., additional, Jepson, Kevin, additional, Goya, Rodrigo, additional, Smith, Maia A., additional, Collins, David W., additional, Pellacani, Davide, additional, Xiang, Ping, additional, de Puyraimond, Valentine, additional, Ricicova, Marketa, additional, Devorkin, Lindsay, additional, Pritchard, Caitlin, additional, O’Neill, Aoise, additional, Dalal, Kush, additional, Panwar, Pankaj, additional, Dhupar, Harveer, additional, Garces, Fabian A., additional, Cohen, Courtney A., additional, Dye, John M., additional, Huie, Kathleen E., additional, Badger, Catherine V., additional, Kobasa, Darwyn, additional, Audet, Jonathan, additional, Freitas, Joshua J., additional, Hassanali, Saleema, additional, Hughes, Ina, additional, Munoz, Luis, additional, Palma, Holly C., additional, Ramamurthy, Bharathi, additional, Cross, Robert W., additional, Geisbert, Thomas W., additional, Menacherry, Vineet, additional, Lokugamage, Kumari, additional, Borisevich, Viktoriya, additional, Lanz, Iliana, additional, Anderson, Lisa, additional, Sipahimalani, Payal, additional, Corbett, Kizzmekia S., additional, Yang, Eun Sung, additional, Zhang, Yi, additional, Shi, Wei, additional, Zhou, Tongqing, additional, Choe, Misook, additional, Misasi, John, additional, Kwong, Peter D., additional, Sullivan, Nancy J., additional, Graham, Barney S., additional, Fernandez, Tara L., additional, Hansen, Carl L., additional, Falconer, Ester, additional, Mascola, John R., additional, Jones, Bryan E., additional, and Barnhart, Bryan C., additional

Published
2021
Full Text
View/download PDF

215. A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice

Author

Martinez, David R., primary, Schaefer, Alexandra, additional, Gobeil, Sophie, additional, Li, Dapeng, additional, De la Cruz, Gabriela, additional, Parks, Robert, additional, Lu, Xiaozhi, additional, Barr, Maggie, additional, Manne, Kartik, additional, Mansouri, Katayoun, additional, Edwards, Robert J., additional, Yount, Boyd, additional, Anasti, Kara, additional, Montgomery, Stephanie A., additional, Shen, Shaunna, additional, Zhou, Tongqing, additional, Kwong, Peter D., additional, Graham, Barney S., additional, Mascola, John R., additional, Montefiori, David. C., additional, Alam, Munir, additional, Sempowski, Gregory D., additional, Wiehe, Kevin, additional, Saunders, Kevin O., additional, Acharya, Priyamvada, additional, Haynes, Barton F., additional, and Baric, Ralph S., additional

Published
2021
Full Text
View/download PDF

216. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates

Author

Corbett, Kizzmekia S., primary, Nason, Martha C., additional, Flach, Britta, additional, Gagne, Matthew, additional, O’ Connell, Sarah, additional, Johnston, Timothy S., additional, Shah, Shruti N., additional, Edara, Venkata Viswanadh, additional, Floyd, Katharine, additional, Lai, Lilin, additional, McDanal, Charlene, additional, Francica, Joseph R., additional, Flynn, Barbara, additional, Wu, Kai, additional, Choi, Angela, additional, Koch, Matthew, additional, Abiona, Olubukola M., additional, Werner, Anne P., additional, Alvarado, Gabriela S., additional, Andrew, Shayne F., additional, Donaldson, Mitzi M., additional, Fintzi, Jonathan, additional, Flebbe, Dillon R., additional, Lamb, Evan, additional, Noe, Amy T., additional, Nurmukhambetova, Saule T., additional, Provost, Samantha J., additional, Cook, Anthony, additional, Dodson, Alan, additional, Faudree, Andrew, additional, Greenhouse, Jack, additional, Kar, Swagata, additional, Pessaint, Laurent, additional, Porto, Maciel, additional, Steingrebe, Katelyn, additional, Valentin, Daniel, additional, Zouantcha, Serge, additional, Bock, Kevin W., additional, Minai, Mahnaz, additional, Nagata, Bianca M., additional, Moliva, Juan I., additional, van de Wetering, Renee, additional, Boyoglu-Barnum, Seyhan, additional, Leung, Kwanyee, additional, Shi, Wei, additional, Yang, Eun Sung, additional, Zhang, Yi, additional, Todd, John-Paul M., additional, Wang, Lingshu, additional, Andersen, Hanne, additional, Foulds, Kathryn E., additional, Edwards, Darin K., additional, Mascola, John R., additional, Moore, Ian N., additional, Lewis, Mark G., additional, Carfi, Andrea, additional, Montefiori, David, additional, Suthar, Mehul S., additional, McDermott, Adrian, additional, Sullivan, Nancy J., additional, Roederer, Mario, additional, Douek, Daniel C., additional, Graham, Barney S., additional, and Seder, Robert A., additional

Published
2021
Full Text
View/download PDF

217. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

Author

Wu, Kai, primary, Werner, Anne P., additional, Koch, Matthew, additional, Choi, Angela, additional, Narayanan, Elisabeth, additional, Stewart-Jones, Guillaume B.E., additional, Colpitts, Tonya, additional, Bennett, Hamilton, additional, Boyoglu-Barnum, Seyhan, additional, Shi, Wei, additional, Moliva, Juan I., additional, Sullivan, Nancy J., additional, Graham, Barney S., additional, Carfi, Andrea, additional, Corbett, Kizzmekia S., additional, Seder, Robert A., additional, and Edwards, Darin K., additional

Published
2021
Full Text
View/download PDF

219. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Author

Mukhamedova, Maryam, primary, Wrapp, Daniel, additional, Shen, Chen-Hsiang, additional, Gilman, Morgan S.A., additional, Ruckwardt, Tracy J., additional, Schramm, Chaim A., additional, Ault, Larissa, additional, Chang, Lauren, additional, Derrien-Colemyn, Alexandrine, additional, Lucas, Sarah A.M., additional, Ransier, Amy, additional, Darko, Samuel, additional, Phung, Emily, additional, Wang, Lingshu, additional, Zhang, Yi, additional, Rush, Scott A., additional, Madan, Bharat, additional, Stewart-Jones, Guillaume B.E., additional, Costner, Pamela J., additional, Holman, LaSonji A., additional, Hickman, Somia P., additional, Berkowitz, Nina M., additional, Doria-Rose, Nicole A., additional, Morabito, Kaitlyn M., additional, DeKosky, Brandon J., additional, Gaudinski, Martin R., additional, Chen, Grace L., additional, Crank, Michelle C., additional, Misasi, John, additional, Sullivan, Nancy J., additional, Douek, Daniel C., additional, Kwong, Peter D., additional, Graham, Barney S., additional, McLellan, Jason S., additional, and Mascola, John R., additional

Published
2021
Full Text
View/download PDF

220. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates

Author

Darricarrère, Nicole, primary, Qiu, Yu, additional, Kanekiyo, Masaru, additional, Creanga, Adrian, additional, Gillespie, Rebecca A., additional, Moin, Syed M., additional, Saleh, Jacqueline, additional, Sancho, Jose, additional, Chou, Te-Hui, additional, Zhou, Yanfeng, additional, Zhang, Ruijun, additional, Dai, Shujia, additional, Moody, Anthony, additional, Saunders, Kevin O., additional, Crank, Michelle C., additional, Mascola, John R., additional, Graham, Barney S., additional, Wei, Chih-Jen, additional, and Nabel, Gary J., additional

Published
2021
Full Text
View/download PDF

221. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

Author

Francica, Joseph R., primary, Flynn, Barbara J., additional, Foulds, Kathryn E., additional, Noe, Amy T., additional, Werner, Anne P., additional, Moore, Ian N., additional, Gagne, Matthew, additional, Johnston, Timothy S., additional, Tucker, Courtney, additional, Davis, Rachel L., additional, Flach, Britta, additional, O’Connell, Sarah, additional, Andrew, Shayne F., additional, Lamb, Evan, additional, Flebbe, Dillon R., additional, Nurmukhambetova, Saule T., additional, Donaldson, Mitzi M., additional, Todd, John-Paul M., additional, Zhu, Alex Lee, additional, Atyeo, Caroline, additional, Fischinger, Stephanie, additional, Gorman, Matthew J, additional, Shin, Sally, additional, Edara, Venkata Viswanadh, additional, Floyd, Katharine, additional, Lai, Lilin, additional, Tylor, Alida, additional, McCarthy, Elizabeth, additional, Lecouturier, Valerie, additional, Ruiz, Sophie, additional, Berry, Catherine, additional, Tibbitts, Timothy, additional, Andersen, Hanne, additional, Cook, Anthony, additional, Dodson, Alan, additional, Pessaint, Laurent, additional, Ry, Alex Van, additional, Koutsoukos, Marguerite, additional, Gutzeit, Cindy, additional, Teng, I-Ting, additional, Zhou, Tongqing, additional, Li, Dapeng, additional, Haynes, Barton F., additional, Kwong, Peter D., additional, McDermott, Adrian, additional, Lewis, Mark G., additional, Fu, Tong Ming, additional, Chicz, Roman, additional, van der Most, Robbert, additional, Corbett, Kizzmekia S., additional, Suthar, Mehul S., additional, Alter, Galit, additional, Roederer, Mario, additional, Sullivan, Nancy J., additional, Douek, Daniel C., additional, Graham, Barney S., additional, Casimiro, Danilo, additional, and Seder, Robert A., additional

Published
2021
Full Text
View/download PDF

222. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants

Author

Wang, Lingshu, primary, Zhou, Tongqing, additional, Zhang, Yi, additional, Yang, Eun Sung, additional, Schramm, Chaim A., additional, Shi, Wei, additional, Pegu, Amarendra, additional, Oloninyi, Olamide K., additional, Ransier, Amy, additional, Darko, Samuel, additional, Narpala, Sandeep R., additional, Hatcher, Christian, additional, Martinez, David R., additional, Tsybovsky, Yaroslav, additional, Phung, Emily, additional, Abiona, Olubukola M., additional, Cale, Evan M., additional, Chang, Lauren A., additional, Corbett, Kizzmekia S., additional, DiPiazza, Anthony T., additional, Gordon, Ingelise J., additional, Leung, Kwanyee, additional, Liu, Tracy, additional, Mason, Rosemarie D., additional, Nazzari, Alexandra, additional, Novik, Laura, additional, Olia, Adam S., additional, Doria-Rose, Nicole A., additional, Stephens, Tyler, additional, Stringham, Christopher D., additional, Talana, Chloe Adrienna, additional, Teng, I-Ting, additional, Wagner, Danielle, additional, Widge, Alicia T., additional, Zhang, Baoshan, additional, Roederer, Mario, additional, Ledgerwood, Julie E., additional, Ruckwardt, Tracy J., additional, Gaudinski, Martin R., additional, Baric, Ralph S., additional, Graham, Barney S., additional, McDermott, Adrian B., additional, Douek, Daniel C., additional, Kwong, Peter D., additional, Mascola, John R, additional, Sullivan, Nancy J., additional, and Misasi, John, additional

Published
2021
Full Text
View/download PDF

223. Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients

Author

Fahad, Ahmed S., primary, Timm, Morgan R., additional, Madan, Bharat, additional, Burgomaster, Katherine E., additional, Dowd, Kimberly A., additional, Normandin, Erica, additional, Gutiérrez-González, Matías F., additional, Pennington, Joseph M., additional, De Souza, Matheus Oliveira, additional, Henry, Amy R., additional, Laboune, Farida, additional, Wang, Lingshu, additional, Ambrozak, David R., additional, Gordon, Ingelise J., additional, Douek, Daniel C., additional, Ledgerwood, Julie E., additional, Graham, Barney S., additional, Castilho, Leda R., additional, Pierson, Theodore C., additional, Mascola, John R., additional, and DeKosky, Brandon J., additional

Published
2021
Full Text
View/download PDF

224. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Author

Baden, Lindsey R., primary, El Sahly, Hana M., additional, Essink, Brandon, additional, Kotloff, Karen, additional, Frey, Sharon, additional, Novak, Rick, additional, Diemert, David, additional, Spector, Stephen A., additional, Rouphael, Nadine, additional, Creech, C. Buddy, additional, McGettigan, John, additional, Khetan, Shishir, additional, Segall, Nathan, additional, Solis, Joel, additional, Brosz, Adam, additional, Fierro, Carlos, additional, Schwartz, Howard, additional, Neuzil, Kathleen, additional, Corey, Lawrence, additional, Gilbert, Peter, additional, Janes, Holly, additional, Follmann, Dean, additional, Marovich, Mary, additional, Mascola, John, additional, Polakowski, Laura, additional, Ledgerwood, Julie, additional, Graham, Barney S., additional, Bennett, Hamilton, additional, Pajon, Rolando, additional, Knightly, Conor, additional, Leav, Brett, additional, Deng, Weiping, additional, Zhou, Honghong, additional, Han, Shu, additional, Ivarsson, Melanie, additional, Miller, Jacqueline, additional, and Zaks, Tal, additional

Published
2021
Full Text
View/download PDF

225. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

Author

Hammer, Scott M., Sobieszczyk, Magdalena E., Janes, Holly, Karuna, Shelly T., Mulligan, Mark J., Grove, Doug, Koblin, Beryl A., Buchbinder, Susan P., Keefer, Michael C., Tomaras, Georgia D., Frahm, Nicole, Hural, John, Anude, Chuka, Graham, Barney S., Enama, Mary E., Adams, Elizabeth, DeJesus, Edwin, Novak, Richard M., Frank, Ian, Bentley, Carter, Ramirez, Shelly, Fu, Rong, Koup, Richard A., Mascola, John R., Nabel, Gary J., Montefiori, David C., Kublin, James, McElrath, Juliana M., Corey, Lawrence, and Gilbert, Peter B.

Published
2013
Full Text
View/download PDF

226. Broad neutralization of SARS-related viruses by human monoclonal antibodies

Author

Dieterle, M. Eugenia, McLellan, Jason S., Wrapp, Daniel, Walker, Laura M., Hsieh, Ching-Lin, Burton, Dennis, Sinclair, Melanie, Lilov, Asparouh, Jangra, Rohit K., Huang, Deli, Sakharkar, Mrunal, Johnson, Carl, Wec, Anna Z., O'Brien, Cecilia M., Voss, James E., Nemazee, David, Brown, Michael, Chandran, Kartik, Nett, Juergen H., Lin, Shu, Wang, Nianshuang, Burnina, Irina, Dye, John M., Haslwanter, Denise, Graham, Barney S., Fels, J. Maximilian, Herbert, Andrew S., Johnson, Nicole V., Maurer, Daniel P., Tse, Longping V., Champney, Elizabeth, and Baric, Ralph S.

Subjects
body regions, fungi, virus diseases, skin and connective tissue diseases
Abstract

Broadly protective vaccines against known and preemergent human coronaviruses (HCoVs) are urgently needed. To gain a deeper understanding of cross-neutralizing antibody responses, we mined the memory B cell repertoire of a convalescent severe acute respiratory syndrome (SARS) donor and identified 200 SARS coronavirus 2 (SARS-CoV-2) binding antibodies that target multiple conserved sites on the spike (S) protein. A large proportion of the non-neutralizing antibodies display high levels of somatic hypermutation and cross-react with circulating HCoVs, suggesting recall of preexisting memory B cells elicited by prior HCoV infections. Several antibodies potently cross-neutralize SARS-CoV, SARS-CoV-2, and the bat SARS-like virus WIV1 by blocking receptor attachment and inducing S1 shedding. These antibodies represent promising candidates for therapeutic intervention and reveal a target for the rational design of pan-sarbecovirus vaccines.

Published
2020
Full Text
View/download PDF

227. Safety and immunogenicity of a gag-pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects

Author

Tavel, Jorge A., Martin, Julie E., Kelly, Grace G., Enama, Mary E., Shen, Jean M., Gomez, Phillip L., Andrews, Charla A., Koup, Richard A., Bailer, Robert T., Stein, Judy A., Roederer, Mario, Nabel, Gary J., and Graham, Barney S.

Subjects
DNA vaccines -- Dosage and administration, HIV infection -- Care and treatment, Hypodermic jet injectors -- Usage, Health
Abstract

The safety and immunogenicity of a candidate HIV DNA vaccine administered by using a needle-free device is evaluated. The results have shown that the HIV DNA vaccine is safe and well tolerated and it has led to the development of a 4-plasmid multiclade HIV DNA Vaccine Research Center vaccine candidate in which envelope genes expressing Env from clades A, B, and C and Nef gene from clade B is added.

Published
2007

228. Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus

Author

Massachusetts Institute of Technology. Institute for Medical Engineering & Science, Massachusetts Institute of Technology. Department of Chemistry, Broad Institute of MIT and Harvard, Koch Institute for Integrative Cancer Research at MIT, Sangesland, Maya, Ronsard, Larance, Kazer, Samuel Weisgurt, Bals, Julia, Boyoglu-Barnum, Seyhan, Yousif, Ashraf S., Barnes, Ralston, Feldman, Jared, Quirindongo-Crespo, Maricel, McTamney, Patrick M., Rohrer, Daniel, Lonberg, Nils, Chackerian, Bryce, Graham, Barney S., Kanekiyo, Masaru, Shalek, Alexander K, Lingwood, Daniel, Massachusetts Institute of Technology. Institute for Medical Engineering & Science, Massachusetts Institute of Technology. Department of Chemistry, Broad Institute of MIT and Harvard, Koch Institute for Integrative Cancer Research at MIT, Sangesland, Maya, Ronsard, Larance, Kazer, Samuel Weisgurt, Bals, Julia, Boyoglu-Barnum, Seyhan, Yousif, Ashraf S., Barnes, Ralston, Feldman, Jared, Quirindongo-Crespo, Maricel, McTamney, Patrick M., Rohrer, Daniel, Lonberg, Nils, Chackerian, Bryce, Graham, Barney S., Kanekiyo, Masaru, Shalek, Alexander K, and Lingwood, Daniel

Abstract

Antibody paratopes are formed by hypervariable complementarity-determining regions (CDRH3s) and variable gene-encoded CDRs. The latter show biased usage in human broadly neutralizing antibodies (bnAbs) against both HIV and influenza virus, suggesting the existence of gene-endowed targeting solutions that may be amenable to pathway amplification. To test this, we generated transgenic mice with human CDRH3 diversity but simultaneously constrained to individual user-defined human immunoglobulin variable heavy-chain (VH) genes, including IGHV1-69, which shows biased usage in human bnAbs targeting the hemagglutinin stalk of group 1 influenza A viruses. Sequential immunization with a stalk-only hemagglutinin nanoparticle elicited group 1 bnAbs, but only in IGHV1-69 mice. This VH-endowed response required minimal affinity maturation, was elicited alongside pre-existing influenza immunity, and when IGHV1-69 B cells were diluted to match the frequency measured in humans. These results indicate that the human repertoire could, in principle, support germline-encoded bnAb elicitation using a single recombinant hemagglutinin immunogen., NIH (Grants 1DP2OD020839, 2U19AI089992, 1U54CA217377, P01AI039671, 5U24AI118672, 2RM1HG006193, 1R33CA202820, 2R01HL095791, 1R01AI138546, 1R01HL126554, 1R01DA046277, 2R01HL095791), Bill and Melinda Gates Foundation (Grants OPP1139972 and BMGF OPP1116944)

Published
2020

232. Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Author

Wang, Pengfei, primary, Nair, Manoj S., additional, Liu, Lihong, additional, Iketani, Sho, additional, Luo, Yang, additional, Guo, Yicheng, additional, Wang, Maple, additional, Yu, Jian, additional, Zhang, Baoshan, additional, Kwong, Peter D., additional, Graham, Barney S., additional, Mascola, John R., additional, Chang, Jennifer Y., additional, Yin, Michael T., additional, Sobieszczyk, Magdalena, additional, Kyratsous, Christos A., additional, Shapiro, Lawrence, additional, Sheng, Zizhang, additional, Huang, Yaoxing, additional, and Ho, David D., additional

Published
2021
Full Text
View/download PDF

233. mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge

Author

Meyer, Michelle, primary, Wang, Yuan, additional, Edwards, Darin, additional, Smith, Gregory R., additional, Rubenstein, Aliza B., additional, Ramanathan, Palaniappan, additional, Mire, Chad E., additional, Pietzsch, Colette, additional, Chen, Xi, additional, Ge, Yongchao, additional, Cheng, Wan Sze, additional, Henry, Carole, additional, Woods, Angela, additional, Ma, LingZhi, additional, Stewart-Jones, Guillaume B. E., additional, Bock, Kevin W., additional, Minai, Mahnaz, additional, Nagata, Bianca M., additional, Periasamy, Sivakumar, additional, Shi, Pei-Yong, additional, Graham, Barney S., additional, Moore, Ian N., additional, Ramos, Irene, additional, Troyanskaya, Olga G., additional, Zaslavsky, Elena, additional, Carfi, Andrea, additional, Sealfon, Stuart C., additional, and Bukreyev, Alexander, additional

Published
2021
Full Text
View/download PDF

234. mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants

Author

Wu, Kai, primary, Werner, Anne P., additional, Moliva, Juan I., additional, Koch, Matthew, additional, Choi, Angela, additional, Stewart-Jones, Guillaume B. E., additional, Bennett, Hamilton, additional, Boyoglu-Barnum, Seyhan, additional, Shi, Wei, additional, Graham, Barney S., additional, Carfi, Andrea, additional, Corbett, Kizzmekia S., additional, Seder, Robert A., additional, and Edwards, Darin K., additional

Published
2021
Full Text
View/download PDF

235. Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

Author

Yang, Yongping, primary, Shi, Wei, additional, Abiona, Olubukola M., additional, Nazzari, Alexandra, additional, Olia, Adam S., additional, Ou, Li, additional, Phung, Emily, additional, Stephens, Tyler, additional, Tsybovsky, Yaroslav, additional, Verardi, Raffaello, additional, Wang, Shuishu, additional, Werner, Anne, additional, Yap, Christina, additional, Ambrozak, David, additional, Bylund, Tatsiana, additional, Liu, Tracy, additional, Nguyen, Richard, additional, Wang, Lingshu, additional, Zhang, Baoshan, additional, Zhou, Tongqing, additional, Chuang, Gwo-Yu, additional, Graham, Barney S., additional, Mascola, John R., additional, Corbett, Kizzmekia S., additional, and Kwong, Peter D., additional

Published
2021
Full Text
View/download PDF

236. Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes

Author

Gutiérrez-González, Matias, primary, Fahad, Ahmed S., additional, Ardito, Matt, additional, Nanaware, Padma, additional, Lu, Liying, additional, Normandin, Erica, additional, Madan, Bharat, additional, Tivin, Jacob, additional, Coates, Emily, additional, Henry, Amy R., additional, Laboune, Farida, additional, Graham, Barney S., additional, Douek, Daniel C., additional, Ledgerwood, Julie E., additional, Mascola, John R., additional, Martin, William D., additional, Stern, Lawrence J., additional, De Groot, Annie S., additional, and DeKosky, Brandon J., additional

Published
2021
Full Text
View/download PDF

237. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Author

Widge, Alicia T., primary, Rouphael, Nadine G., additional, Jackson, Lisa A., additional, Anderson, Evan J., additional, Roberts, Paul C., additional, Makhene, Mamodikoe, additional, Chappell, James D., additional, Denison, Mark R., additional, Stevens, Laura J., additional, Pruijssers, Andrea J., additional, McDermott, Adrian B., additional, Flach, Britta, additional, Lin, Bob C., additional, Doria-Rose, Nicole A., additional, O’Dell, Sijy, additional, Schmidt, Stephen D., additional, Neuzil, Kathleen M., additional, Bennett, Hamilton, additional, Leav, Brett, additional, Makowski, Mat, additional, Albert, Jim, additional, Cross, Kaitlyn, additional, Edara, Venkata-Viswanadh, additional, Floyd, Katharine, additional, Suthar, Mehul S., additional, Buchanan, Wendy, additional, Luke, Catherine J., additional, Ledgerwood, Julie E., additional, Mascola, John R., additional, Graham, Barney S., additional, and Beigel, John H., additional

Published
2021
Full Text
View/download PDF

238. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

Author

Li, Dapeng, primary, Edwards, Robert J, additional, Manne, Kartik, additional, Martinez, David R., additional, Schäfer, Alexandra, additional, Alam, S. Munir, additional, Wiehe, Kevin, additional, Lu, Xiaozhi, additional, Parks, Robert, additional, Sutherland, Laura L., additional, Oguin, Thomas H., additional, McDanal, Charlene, additional, Perez, Lautaro G., additional, Mansouri, Katayoun, additional, Gobeil, Sophie M. C., additional, Janowska, Katarzyna, additional, Stalls, Victoria, additional, Kopp, Megan, additional, Cai, Fangping, additional, Lee, Esther, additional, Foulger, Andrew, additional, Hernandez, Giovanna E., additional, Sanzone, Aja, additional, Tilahun, Kedamawit, additional, Jiang, Chuancang, additional, Tse, Longping V., additional, Bock, Kevin W., additional, Minai, Mahnaz, additional, Nagata, Bianca M., additional, Cronin, Kenneth, additional, Gee-Lai, Victoria, additional, Deyton, Margaret, additional, Barr, Maggie, additional, Holle, Tarra Von, additional, Macintyre, Andrew N., additional, Stover, Erica, additional, Feldman, Jared, additional, Hauser, Blake M., additional, Caradonna, Timothy M., additional, Scobey, Trevor D., additional, Rountree, Wes, additional, Wang, Yunfei, additional, Moody, M. Anthony, additional, Cain, Derek W., additional, DeMarco, C. Todd, additional, Denny, ThomasN., additional, Woods, Christopher W., additional, Petzold, Elizabeth W., additional, Schmidt, Aaron G., additional, Teng, I-Ting, additional, Zhou, Tongqing, additional, Kwong, Peter D., additional, Mascola, John R., additional, Graham, Barney S., additional, Moore, Ian N., additional, Seder, Robert, additional, Andersen, Hanne, additional, Lewis, Mark G., additional, Montefiori, David C., additional, Sempowski, Gregory D., additional, Baric, Ralph S., additional, Acharya, Priyamvada, additional, Haynes, Barton F., additional, and Saunders, Kevin O., additional

Published
2021
Full Text
View/download PDF

239. Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions

Author

Shiakolas, Andrea R., primary, Kramer, Kevin J., additional, Wrapp, Daniel, additional, Richardson, Simone I., additional, Schäfer, Alexandra, additional, Wall, Steven, additional, Wang, Nianshuang, additional, Janowska, Katarzyna, additional, Pilewski, Kelsey A., additional, Venkat, Rohit, additional, Parks, Rob, additional, Manamela, Nelia P., additional, Raju, Nagarajan, additional, Fechter, Emilee Friedman, additional, Holt, Clinton M., additional, Suryadevara, Naveenchandra, additional, Chen, Rita E., additional, Martinez, David R., additional, Nargi, Rachel S., additional, Sutton, Rachel E., additional, Ledgerwood, Julie E., additional, Graham, Barney S., additional, Diamond, Michael S., additional, Haynes, Barton F., additional, Acharya, Priyamvada, additional, Carnahan, Robert H., additional, Crowe, James E., additional, Baric, Ralph S., additional, Morris, Lynn, additional, McLellan, Jason S., additional, and Georgiev, Ivelin S., additional

Published
2020
Full Text
View/download PDF

240. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Author

Anderson, Evan J., primary, Rouphael, Nadine G., additional, Widge, Alicia T., additional, Jackson, Lisa A., additional, Roberts, Paul C., additional, Makhene, Mamodikoe, additional, Chappell, James D., additional, Denison, Mark R., additional, Stevens, Laura J., additional, Pruijssers, Andrea J., additional, McDermott, Adrian B., additional, Flach, Britta, additional, Lin, Bob C., additional, Doria-Rose, Nicole A., additional, O’Dell, Sijy, additional, Schmidt, Stephen D., additional, Corbett, Kizzmekia S., additional, Swanson, Phillip A., additional, Padilla, Marcelino, additional, Neuzil, Kathy M., additional, Bennett, Hamilton, additional, Leav, Brett, additional, Makowski, Mat, additional, Albert, Jim, additional, Cross, Kaitlyn, additional, Edara, Venkata Viswanadh, additional, Floyd, Katharine, additional, Suthar, Mehul S., additional, Martinez, David R., additional, Baric, Ralph, additional, Buchanan, Wendy, additional, Luke, Catherine J., additional, Phadke, Varun K., additional, Rostad, Christina A., additional, Ledgerwood, Julie E., additional, Graham, Barney S., additional, and Beigel, John H., additional

Published
2020
Full Text
View/download PDF

242. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Author

Jackson, Lisa A., primary, Anderson, Evan J., additional, Rouphael, Nadine G., additional, Roberts, Paul C., additional, Makhene, Mamodikoe, additional, Coler, Rhea N., additional, McCullough, Michele P., additional, Chappell, James D., additional, Denison, Mark R., additional, Stevens, Laura J., additional, Pruijssers, Andrea J., additional, McDermott, Adrian, additional, Flach, Britta, additional, Doria-Rose, Nicole A., additional, Corbett, Kizzmekia S., additional, Morabito, Kaitlyn M., additional, O’Dell, Sijy, additional, Schmidt, Stephen D., additional, Swanson, Phillip A., additional, Padilla, Marcelino, additional, Mascola, John R., additional, Neuzil, Kathleen M., additional, Bennett, Hamilton, additional, Sun, Wellington, additional, Peters, Etza, additional, Makowski, Mat, additional, Albert, Jim, additional, Cross, Kaitlyn, additional, Buchanan, Wendy, additional, Pikaart-Tautges, Rhonda, additional, Ledgerwood, Julie E., additional, Graham, Barney S., additional, and Beigel, John H., additional

Published
2020
Full Text
View/download PDF

243. Modified vaccinia Ankara: potential as an alternative smallpox vaccine

Author

McCurdy, Lewis H., Larkin, Brenda D., Martin, Julie E., and Graham, Barney S.

Subjects
Smallpox vaccine -- Health aspects, Bioterrorism -- Influence, Smallpox -- Care and treatment, Smallpox -- Development and progression, Smallpox -- Research, Health, Health care industry
Published
2004

247. Clinical trials of HIV vaccines

Author

Graham, Barney S.

Subjects
Vaccines -- Design and construction, HIV (Viruses) -- Physiological aspects, Immunogenetics -- Research, T cells -- Differentiation, Anti-antibodies -- Physiological aspects, Health
Abstract

This review summarizes the research, development, and clinical evaluation of vaccines for preventing HIV infection and control of the Aquired Immunodeficiency Syndrome (AIDS). Animal models reveal that sufficient levels of neutralizing antibody against HIV can be generated in vivo, leading to the possibility of achieving immunity against HIV.

Published
2002

248. Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

Author

Schmidt, Claudia, Smith, Carol, Barin, Burc, Bakhtyari, Arash, Bart, Pierre-Alexandre, Bekker, Linda-Gail, Chomba, Elwyn, Clumeck, Nathan, Ho, David, Hoosen, Anwar, Jaoko, Walter, Kaleebu, Pontiano, Karita, Etienne, Keefer, Michael C., van Lunzen, Jan, McMichael, Andrew, Mehendale, Sanjay, Peters, Barry, Ramanathan, Vadakkuppatu D., Robinson, Andrew, Rockstroh, Juergen, Vardas, Eftyhia, Vets, Eva, Weber, Jonathan, Graham, Barney S., Than, Soe, Excler, Jean-Louis, Kochhar, Sonali, Ho, Martin, Heald, Alison, and Fast, Patricia E.

Published
2012

250. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Author

Corbett, Kizzmekia S., primary, Flynn, Barbara, additional, Foulds, Kathryn E., additional, Francica, Joseph R., additional, Boyoglu-Barnum, Seyhan, additional, Werner, Anne P., additional, Flach, Britta, additional, O’Connell, Sarah, additional, Bock, Kevin W., additional, Minai, Mahnaz, additional, Nagata, Bianca M., additional, Andersen, Hanne, additional, Martinez, David R., additional, Noe, Amy T., additional, Douek, Naomi, additional, Donaldson, Mitzi M., additional, Nji, Nadesh N., additional, Alvarado, Gabriela S., additional, Edwards, Darin K., additional, Flebbe, Dillon R., additional, Lamb, Evan, additional, Doria-Rose, Nicole A., additional, Lin, Bob C., additional, Louder, Mark K., additional, O’Dell, Sijy, additional, Schmidt, Stephen D., additional, Phung, Emily, additional, Chang, Lauren A., additional, Yap, Christina, additional, Todd, John-Paul M., additional, Pessaint, Laurent, additional, Van Ry, Alex, additional, Browne, Shanai, additional, Greenhouse, Jack, additional, Putman-Taylor, Tammy, additional, Strasbaugh, Amanda, additional, Campbell, Tracey-Ann, additional, Cook, Anthony, additional, Dodson, Alan, additional, Steingrebe, Katelyn, additional, Shi, Wei, additional, Zhang, Yi, additional, Abiona, Olubukola M., additional, Wang, Lingshu, additional, Pegu, Amarendra, additional, Yang, Eun Sung, additional, Leung, Kwanyee, additional, Zhou, Tongqing, additional, Teng, I-Ting, additional, Widge, Alicia, additional, Gordon, Ingelise, additional, Novik, Laura, additional, Gillespie, Rebecca A., additional, Loomis, Rebecca J., additional, Moliva, Juan I., additional, Stewart-Jones, Guillaume, additional, Himansu, Sunny, additional, Kong, Wing-Pui, additional, Nason, Martha C., additional, Morabito, Kaitlyn M., additional, Ruckwardt, Tracy J., additional, Ledgerwood, Julie E., additional, Gaudinski, Martin R., additional, Kwong, Peter D., additional, Mascola, John R., additional, Carfi, Andrea, additional, Lewis, Mark G., additional, Baric, Ralph S., additional, McDermott, Adrian, additional, Moore, Ian N., additional, Sullivan, Nancy J., additional, Roederer, Mario, additional, Seder, Robert A., additional, and Graham, Barney S., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results